Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

AVLN Interest Income

Income earned on cash, deposits, and investments held by the company.

No reported Interest Income figures are available to summarize.

Interest Income history

Currency unavailable · from the income statement

No Interest Income data reported for this period type.

Interest Income vs competitors

How AVLN compares with its peers on the latest reported figures

AVLN Competitors
Interest Income for AVLN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INSMInsmed IncorporatedLTM Jun 2026$45.57M USD-25.8%+76.2%4.0%
VCREVicore Pharma Holding ABLTM Jun 2026SEK 21.37M SEK+23.9%+196.9%1607.1%
MNKDMannKind CorporationLTM Mar 2026$9.68M USD-13.1%—2.7%
GYREGyre Therapeutics, Inc.LTM Mar 2026$1.01M USD-28.9%+34.0%0.9%
AVLNAvalyn Pharma Inc. Common Stock—— ———
Peer median (excluding AVLN) —-19.4%+76.2%3.3%

Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Intrinsic Alpha fair value

Locked

Current Price

$27.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.